what to expect when switching from semaglutide to tirzepatide Tirzepatide: Is It Safe? Transitioning Treatments: What to Expect

Research suggests that ceasing treatment results in regaining weight within 6-12 months, so sustainable changes in eating and activity are crucial

This can make the medicine less effective in lowering blood sugar and helping with weight loss

Compound identity at a glance Name: Retatrutide INN: LY3437943 Class: Triple incretin receptor agonist Structure: 39-amino-acid synthetic peptide Dosing interval: Once weekly (research protocols) Developer: Eli Lilly For the full molecular reference (molecular formula, molecular weight, CAS number and the 39-amino-acid sequence) see the Retatrutide molecular profile

Beets are a type of root vegetable that many consider a superfood